BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
| Revenue (TTM) | $7.42M |
| Gross Profit (TTM) | $1.09M |
| EBITDA | $-2.99M |
| Operating Margin | -231.50% |
| Return on Equity | -35.20% |
| Return on Assets | -19.70% |
| Revenue/Share (TTM) | $4.00 |
| Book Value | $3.56 |
| Price-to-Book | 0.58 |
| Price-to-Sales (TTM) | 0.66 |
| EV/Revenue | 0.156 |
| EV/EBITDA | 667.04 |
| Quarterly Earnings Growth (YoY) | -95.00% |
| Quarterly Revenue Growth (YoY) | -80.80% |
| Shares Outstanding | $2.42M |
| Float | $1.75M |
| % Insiders | 35.59% |
| % Institutions | 1.98% |
Volatility is currently contracting